All Articles

Canada's new Digital Safety Act could ban social media for kids under 16 and create a new regulator. What does this mean for Big Tech's bottom line?

Hitachi's Young Leaders Initiative is more than a conference; it's a strategic investment in Asia's future. Here's how it turns theory into practice.

Autonomous AI agents are multiplying in corporate networks, unseen and ungoverned. A new security category, 'AI Agent Governance,' aims to stop a crisis.

As attackers arm themselves with AI, a new breed of defense is emerging. Zimperium's recent leadership nod reveals a critical shift to embedded AI security.

A new study reveals the biggest planning mistake in enterprise IT is rigid strategy. For companies betting on digital transformation, adaptability is now survival.

Your money-saving travel eSIM might lock you out of your bank account. A new analysis reveals the hidden risks of data-only connectivity for travelers.

Sameer Kanodia’s back-to-back CEO awards are more than accolades. They signal a systemic shift where people-centric culture is the new engine of global growth.

With a key government veteran hire and a high-profile summit, Robo.ai's subsidiary isn't just entering the UAE market; it's embedding itself into its digital DNA.

A new partnership between software specialist Cosylab and hardware innovator Heron aims to overcome the final hurdles in deploying a promising cancer therapy worldwide.

Vision Marine's extended partnership with Nextfour isn't just a supply deal; it's a strategic move to define the user experience in electric boating.

In a market drowning in price wars, one LED maker is thriving by rejecting scale for strategy. Absen's focus on value and efficiency offers a blueprint for survival.

A new study finds 71% of data transformations pivot mid-project. This exposes the fatal flaw in rigid planning and makes the case for adaptive strategies.

Health Canada's Priority Review for a new Duchenne muscular dystrophy drug signals hope for patients and a strategic test of Canada's rare disease market.

ChipMOS Technologies' May revenue surged 17.7% year-over-year, fueled by AI chip demand. Despite a minor monthly dip, the firm is expanding capacity.

A UK firm's regulatory milestone is more than just compliance; it's a strategic masterclass in building the resilient systems needed to fight food allergies.

Questex's Fierce Biotech is launching a UK event, but this is more than expansion. It’s a calculated bet on London's future as a biotech superpower.

Logitech's new Mobi Fold isn't just a clever gadget. It's a strategic assault on the trackpad, aiming to close the productivity gap for hybrid professionals.

A strategic pivot from commercial real estate to the hard assets of the new economy reveals where the smart money is flowing—and it’s not just into buildings.

As new drugs outpace manufacturing capacity, a French giant bets on local production in China to build the supply chains of tomorrow's therapies.

A groundbreaking partnership between Servier and n-Lorem Foundation blends pharma R&D muscle with non-profit agility to develop ASO therapies for the rarest of diseases.